These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 14607948

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection.
    Guillonneau C, Louvet C, Renaudin K, Heslan JM, Heslan M, Tesson L, Vignes C, Guillot C, Choi Y, Turka LA, Cuturi MC, Anegon I, Josien R.
    J Immunol; 2004 Feb 01; 172(3):1619-29. PubMed ID: 14734743
    [Abstract] [Full Text] [Related]

  • 3. The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation.
    Padigel UM, Perrin PJ, Farrell JP.
    J Immunol; 2001 Nov 15; 167(10):5874-9. PubMed ID: 11698463
    [Abstract] [Full Text] [Related]

  • 4. Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major.
    Okwor I, Jia P, Uzonna JE.
    J Immunol; 2015 Oct 01; 195(7):3218-26. PubMed ID: 26304989
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhanced secretion of IFN-gamma by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine.
    Chen NJ, Huang MW, Hsieh SL.
    J Immunol; 2001 Jan 01; 166(1):270-6. PubMed ID: 11123302
    [Abstract] [Full Text] [Related]

  • 7. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation.
    Bachmann MF, Wong BR, Josien R, Steinman RM, Oxenius A, Choi Y.
    J Exp Med; 1999 Apr 05; 189(7):1025-31. PubMed ID: 10190893
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Disabling of receptor activator of nuclear factor-kappaB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivo.
    Cheng X, Kinosaki M, Takami M, Choi Y, Zhang H, Murali R.
    J Biol Chem; 2004 Feb 27; 279(9):8269-77. PubMed ID: 14679212
    [Abstract] [Full Text] [Related]

  • 10. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
    Wiethe C, Dittmar K, Doan T, Lindenmaier W, Tindle R.
    J Immunol; 2003 Oct 15; 171(8):4121-30. PubMed ID: 14530334
    [Abstract] [Full Text] [Related]

  • 11. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection.
    Jones DE, Buxbaum LU, Scott P.
    J Immunol; 2000 Jul 01; 165(1):364-72. PubMed ID: 10861073
    [Abstract] [Full Text] [Related]

  • 12. CD40 ligand is required for protective cell-mediated immunity to Leishmania major.
    Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR.
    Immunity; 1996 Mar 01; 4(3):283-9. PubMed ID: 8624818
    [Abstract] [Full Text] [Related]

  • 13. RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.
    Sordillo EM, Pearse RN.
    Cancer; 2003 Feb 01; 97(3 Suppl):802-12. PubMed ID: 12548579
    [Abstract] [Full Text] [Related]

  • 14. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major.
    Mbow ML, Bleyenberg JA, Hall LR, Titus RG.
    J Immunol; 1998 Nov 15; 161(10):5571-7. PubMed ID: 9820534
    [Abstract] [Full Text] [Related]

  • 15. TRANCE together with IL-7 induces pre-B cells to proliferate.
    Kato I, Sato H, Kudo A.
    Eur J Immunol; 2003 Feb 15; 33(2):334-41. PubMed ID: 12548564
    [Abstract] [Full Text] [Related]

  • 16. BALB/c mice bearing a transgenic IL-12 receptor beta 2 gene exhibit a nonhealing phenotype to Leishmania major infection despite intact IL-12 signaling.
    Nishikomori R, Gurunathan S, Nishikomori K, Strober W.
    J Immunol; 2001 Jun 01; 166(11):6776-83. PubMed ID: 11359836
    [Abstract] [Full Text] [Related]

  • 17. NF-kappa B1 is required for optimal CD4+ Th1 cell development and resistance to Leishmania major.
    Artis D, Speirs K, Joyce K, Goldschmidt M, Caamaño J, Hunter CA, Scott P.
    J Immunol; 2003 Feb 15; 170(4):1995-2003. PubMed ID: 12574369
    [Abstract] [Full Text] [Related]

  • 18. TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions.
    Abou Fakher FH, Rachinel N, Klimczak M, Louis J, Doyen N.
    J Immunol; 2009 Feb 01; 182(3):1386-96. PubMed ID: 19155485
    [Abstract] [Full Text] [Related]

  • 19. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4.
    Fernandez-Botran R, Chilton PM, Hondowicz BD, Vetvickova J, Yan J, Jones W, Scott P.
    J Leukoc Biol; 1999 Sep 01; 66(3):481-8. PubMed ID: 10496319
    [Abstract] [Full Text] [Related]

  • 20. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.
    Padigel UM, Farrell JP.
    J Immunol; 2005 May 15; 174(10):6340-5. PubMed ID: 15879134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.